In summary, our results demonstrate that chemotherapy protocol, age, WBC, and mll-r status are all independent, significant predictors of outcome among childhood B-ALL but not ETV6/RUNX1 status. This evidence concerns the gene RUNX1 and precursor B-cell acute lymphoblastic leukemia.